Preview

Meditsinskiy sovet = Medical Council

Advanced search

Non-alcoholic fatty liver disease: new therapeutic options

https://doi.org/10.21518/2079-701X-2014-13-18-21

Abstract

The past decades have recorded sustainably high incidence of non-alcoholic fatty liver disease (NAFLD) globally. The disease is more prevalent among people with obesity and diabetes mellitus (DM), dyslipidemia and metabolic syndrome (MS) [3, 4]. NAFLD is an independent nosological unit including a range of clinical and morphological changes of the liver parenchyma: steatosis (fatty degeneration) and non-alcoholic steatohepatitis. NAFLD pharmacotherapy asks for a search of new effective methods of treatment.

About the Author

R. G. Myazin
Volgograd State Medical University
Russian Federation


References

1. Ивашкин В.Т. Болезни печени и желчевыводящих путей. М-Вести, 2005: 536.

2. Мехтиев С.Н., Гриневич В.Б., Кравчук Ю.А., Бращенкова А.В. Неалкогольная жировая болезнь печени: клиника, диагностика и лечение. Лечащий врач, 2008, 2: 24-28.

3. Feldstein AE et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalhocolic fatty liver disease. Hepatology 2006, 44: 27-33.

4. Hamaguchi M, Koima T, Takeda N et al. The metabolic syndromas a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143: 772-8.

5. Павлов Ч.С., Глушенков Д.В., Буличенко М.А., Воробьев А.В., Никонов Е.Л., Ивашкин В.Т Неалкогольная жировая болезнь печени в клинике внутренних болезней. Русский медицинский журнал, 2011, 6: 11-17.

6. Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease.J. Clin. Invest. 2005; 115(5): 1343-51.

7. Garc M.C. Non-alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology, 2001, 24: 395-402.

8. Полунина Т.Е. Неалкогольная жировая болезнь печени. Алгоритм диагностики и лечебной тактики. Пособие для врачей общей практики, терапевтов и гастроэнтерологов. Учебно-методическое пособие. М.: Медиа медика, 2014: 32.


Review

For citations:


Myazin RG. Non-alcoholic fatty liver disease: new therapeutic options. Meditsinskiy sovet = Medical Council. 2014;(13):18-21. (In Russ.) https://doi.org/10.21518/2079-701X-2014-13-18-21

Views: 559


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)